Kingdon Capital Management L.L.C. Has $687,000 Stake in Jaguar Animal Health, Inc. (JAGX)
Kingdon Capital Management L.L.C. maintained its stake in shares of Jaguar Animal Health, Inc. (NASDAQ:JAGX) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,297,815 shares of the biotechnology company’s stock at the close of the 2nd quarter. Kingdon Capital Management L.L.C. owned approximately 7.17% of Jaguar Animal Health worth $687,000 at the end of the most recent quarter.
JAGX has been the subject of several recent research reports. HC Wainwright set a $2.00 price target on Jaguar Animal Health and gave the stock a “buy” rating in a report on Tuesday, July 11th. Rodman & Renshaw initiated coverage on Jaguar Animal Health in a report on Tuesday, July 11th. They set a “buy” rating and a $2.00 price target for the company.
Shares of Jaguar Animal Health, Inc. (NASDAQ:JAGX) traded up 0.96% during midday trading on Friday, reaching $0.21. The company had a trading volume of 3,836,812 shares. Jaguar Animal Health, Inc. has a one year low of $0.17 and a one year high of $1.53. The company has a 50-day moving average price of $0.37 and a 200 day moving average price of $0.37. The company’s market capitalization is $22.72 million.
TRADEMARK VIOLATION WARNING: This story was originally reported by Watch List News and is the property of of Watch List News. If you are viewing this story on another domain, it was illegally copied and republished in violation of United States and international copyright & trademark law. The legal version of this story can be accessed at https://www.watchlistnews.com/kingdon-capital-management-l-l-c-has-687000-stake-in-jaguar-animal-health-inc-jagx/1615602.html.
About Jaguar Animal Health
Jaguar Health, Inc, formerly Jaguar Animal Health, Inc, is a natural-products pharmaceuticals company. The Company is focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis. The Company, through its subsidiary Napo Pharmaceuticals, Inc, is focused on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas.
Want to see what other hedge funds are holding JAGX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Jaguar Animal Health, Inc. (NASDAQ:JAGX).
Receive News & Ratings for Jaguar Animal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Animal Health Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.